Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
- PMID: 24553363
- PMCID: PMC3928962
- DOI: 10.1136/bmj.g1393
Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
Abstract
Objectives: To estimate the frequency and characteristics of opioid prescribing by multiple providers in Medicare and the association with hospital admissions related to opioid use.
Design: Retrospective cohort study.
Setting: Database of prescription drugs and medical claims in 20% random sample of Medicare beneficiaries in 2010.
Participants: 1,808,355 Medicare beneficiaries who filled at least one prescription for an opioid from a pharmacy in 2010.
Main outcome measures: Proportion of beneficiaries who filled opioid prescriptions from multiple providers; proportion of these prescriptions that were concurrently supplied; adjusted rates of hospital admissions related to opioid use associated with multiple provider prescribing.
Results: Among 1,208,100 beneficiaries with an opioid prescription, 418,530 (34.6%) filled prescriptions from two providers, 171,420 (14.2%) from three providers, and 143,344 (11.9%) from four or more providers. Among beneficiaries with four or more opioid providers, 110,671 (77.2%) received concurrent opioid prescriptions from multiple providers, and the dominant provider prescribed less than half of the mean total prescriptions per beneficiary (7.9/15.2 prescriptions). Multiple provider prescribing was highest among beneficiaries who were also prescribed stimulants, non-narcotic analgesics, and central nervous system, neuromuscular, and antineoplastic drugs. Hospital admissions related to opioid use increased with multiple provider prescribing: the annual unadjusted rate of admission was 1.63% (95% confidence interval 1.58 to 1.67%) for beneficiaries with one provider, 2.08% (2.03% to 2.14%) for two providers, 2.87% (2.77% to 2.97%) for three providers, and 4.83% (4.70% to 4.96%) for four or more providers. Results were similar after covariate adjustment.
Conclusions: Concurrent opioid prescribing by multiple providers is common in Medicare patients and is associated with higher rates of hospital admission related to opioid use.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Similar articles
-
Racial and Ethnic Disparities in Opioid Prescribing on Hospital Discharge Among Older Adults: A National Retrospective Cohort Study.J Gen Intern Med. 2024 Jun;39(8):1444-1451. doi: 10.1007/s11606-024-08687-w. Epub 2024 Feb 29. J Gen Intern Med. 2024. PMID: 38424348
-
Opioid and Nonopioid Analgesic Prescribing Patterns of Hepatologists for Medicare Beneficiaries.Clin Transl Gastroenterol. 2024 Oct 1;15(10):e1. doi: 10.14309/ctg.0000000000000729. Clin Transl Gastroenterol. 2024. PMID: 39082613 Free PMC article.
-
Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.Ann Intern Med. 2019 Apr 2;170(7):433-442. doi: 10.7326/M18-2574. Epub 2019 Mar 12. Ann Intern Med. 2019. PMID: 30856660 Free PMC article.
-
Hospital Prescribing of Opioids to Medicare Beneficiaries.JAMA Intern Med. 2016 Jul 1;176(7):990-7. doi: 10.1001/jamainternmed.2016.2737. JAMA Intern Med. 2016. PMID: 27294595 Free PMC article.
-
Correlation of Opioid Mortality with Prescriptions and Social Determinants: A Cross-sectional Study of Medicare Enrollees.Drugs. 2018 Jan;78(1):111-121. doi: 10.1007/s40265-017-0846-6. Drugs. 2018. PMID: 29159797 Review.
Cited by
-
Prescription Opioid Use before and after Diagnosis of Cancer Among Older Cancer Survivors With Non-Cancer Chronic Pain Conditions (NCPCs): An Application of Group-Based Trajectory Modeling (GBTM).Cancer Control. 2024 Jan-Dec;31:10732748241290769. doi: 10.1177/10732748241290769. Cancer Control. 2024. PMID: 39425746 Free PMC article.
-
Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders: Quasi-Experimental Study Using Interrupted Time Series.JMIR Public Health Surveill. 2024 Feb 21;10:e47130. doi: 10.2196/47130. JMIR Public Health Surveill. 2024. PMID: 38381481 Free PMC article.
-
High-risk Prescribing Following Surgery Among Payer Types for Patients on Chronic Opioids.Ann Surg. 2023 Dec 1;278(6):1060-1067. doi: 10.1097/SLA.0000000000005938. Epub 2023 Jun 16. Ann Surg. 2023. PMID: 37335197
-
Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.Res Social Adm Pharm. 2023 Aug;19(8):1171-1177. doi: 10.1016/j.sapharm.2023.04.121. Epub 2023 Apr 23. Res Social Adm Pharm. 2023. PMID: 37142474 Free PMC article.
-
Prescription analgesic overuse in older adults: Can we mitigate this growing problem?Aging Med (Milton). 2022 Nov 15;5(4):294-296. doi: 10.1002/agm2.12228. eCollection 2022 Dec. Aging Med (Milton). 2022. PMID: 36606265 Free PMC article.
References
-
- Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004;109:514-9. - PubMed
-
- Novak S, Nemeth WC, Lawson KA. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004;5:59-65. - PubMed
-
- Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA 2012;308:1865-6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical